Sangamo Biosciences (SGMO) Announces Publication of Positive ZFN Genome-Editing Platform Data
Tweet Send to a Friend
Sangamo Biosciences (Nasdaq: SGMO) announced the publication in Nature Biotechnology of data demonstrating efficient zinc finger nuclease (ZFN)-mediated, targeted gene ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
